Insider Transactions in Q1 2022 at Relay Therapeutics, Inc. (RLAY)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2022
|
Brian Adams Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
333
-0.51%
|
$9,657
$29.87 P/Share
|
|
Mar 29
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
622
-0.66%
|
$18,038
$29.87 P/Share
|
|
Mar 29
2022
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
282
-0.52%
|
$8,178
$29.87 P/Share
|
|
Mar 29
2022
|
Andy Porter Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
294
-0.62%
|
$8,526
$29.87 P/Share
|
|
Mar 24
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
10,000
-9.53%
|
$300,000
$30.0 P/Share
|
|
Mar 24
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.7%
|
$40,000
$4.12 P/Share
|
|
Mar 24
2022
|
Thomas Catinazzo Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13,286
-19.67%
|
$398,580
$30.0 P/Share
|
|
Mar 24
2022
|
Thomas Catinazzo Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,286
+16.44%
|
$53,144
$4.12 P/Share
|
|
Mar 10
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
10,000
-9.53%
|
$250,000
$25.0 P/Share
|
|
Mar 10
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.7%
|
$40,000
$4.12 P/Share
|
|
Mar 01
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
8,000
-7.77%
|
$184,000
$23.88 P/Share
|
|
Mar 01
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+7.21%
|
$32,000
$4.12 P/Share
|
|
Feb 22
2022
|
Donald A Bergstrom President, R&D |
SELL
Open market or private sale
|
Direct |
22,994
-6.91%
|
$459,880
$20.95 P/Share
|
|
Feb 22
2022
|
Donald A Bergstrom President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+6.35%
|
$32,000
$4.12 P/Share
|
|
Jan 27
2022
|
Brian Adams Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,270
+37.69%
|
-
|
|
Jan 27
2022
|
Donald A Bergstrom President, R&D |
BUY
Grant, award, or other acquisition
|
Direct |
64,950
+37.14%
|
-
|
|
Jan 27
2022
|
Thomas Catinazzo Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
39,270
+41.99%
|
-
|
|
Jan 27
2022
|
Andy Porter Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,170
+33.81%
|
-
|